These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Interdependence between degree of porphyrin excess and disease severity in congenital erythropoietic porphyria (Günther's disease). Freesemann AG; Bhutani LK; Jacob K; Doss MO Arch Dermatol Res; 1997 Apr; 289(5):272-6. PubMed ID: 9164637 [TBL] [Abstract][Full Text] [Related]
23. An Atypical Case of Congenital Erythropoietic Porphyria. Sudrié-Arnaud B; Legendre M; Snanoudj S; Pelluard F; Bekri S; Tebani A Genes (Basel); 2021 Nov; 12(11):. PubMed ID: 34828434 [TBL] [Abstract][Full Text] [Related]
24. Acquired erythropoietic uroporphyria secondary to myelodysplastic syndrome with chromosome 3 alterations: a case report. Podlipnik S; Guijarro F; Combalia A; To-Figueras J; Badenas C; Costa D; Rozman M; Jorge S; Aguilera P; Gaya A Br J Dermatol; 2018 Aug; 179(2):486-490. PubMed ID: 28865079 [TBL] [Abstract][Full Text] [Related]
25. Severe neonatal congenital erythropoietic porphyria. Hogeling M; Nakano T; Dvorak CC; Maguiness S; Frieden IJ Pediatr Dermatol; 2011; 28(4):416-20. PubMed ID: 21362030 [TBL] [Abstract][Full Text] [Related]
26. Treatment of congenital erythropoietic porphyria in children by allogeneic stem cell transplantation: a case report and review of the literature. Shaw PH; Mancini AJ; McConnell JP; Brown D; Kletzel M Bone Marrow Transplant; 2001 Jan; 27(1):101-5. PubMed ID: 11244446 [TBL] [Abstract][Full Text] [Related]
27. Therapeutic potential of proteasome inhibitors in congenital erythropoietic porphyria. Blouin JM; Duchartre Y; Costet P; Lalanne M; Ged C; Lain A; Millet O; de Verneuil H; Richard E Proc Natl Acad Sci U S A; 2013 Nov; 110(45):18238-43. PubMed ID: 24145442 [TBL] [Abstract][Full Text] [Related]
28. Congenital erythropoietic porphyria: prolonged high-level expression and correction of the heme biosynthetic defect by retroviral-mediated gene transfer into porphyric and erythroid cells. Kauppinen R; Glass IA; Aizencang G; Astrin KH; Atweh GF; Desnick RJ Mol Genet Metab; 1998 Sep; 65(1):10-7. PubMed ID: 9787090 [TBL] [Abstract][Full Text] [Related]
30. Treatment of severe congenital erythropoietic porphyria by bone marrow transplantation. Harada FA; Shwayder TA; Desnick RJ; Lim HW J Am Acad Dermatol; 2001 Aug; 45(2):279-82. PubMed ID: 11464191 [TBL] [Abstract][Full Text] [Related]
31. The prenatal presentation of congenital erythropoietic porphyria: report of two siblings with elevated maternal serum alpha-fetoprotein. Lazebnik N; Lazebnik RS Prenat Diagn; 2004 Apr; 24(4):282-6. PubMed ID: 15065102 [TBL] [Abstract][Full Text] [Related]
32. Mutational analysis of uroporphyrinogen III cosynthase gene in Iranian families with congenital erythropoietic porphyria. Moghbeli M; Maleknejad M; Arabi A; Abbaszadegan MR Mol Biol Rep; 2012 Jun; 39(6):6731-5. PubMed ID: 22350154 [TBL] [Abstract][Full Text] [Related]
33. Uroporphyrinogen III synthase knock-in mice have the human congenital erythropoietic porphyria phenotype, including the characteristic light-induced cutaneous lesions. Bishop DF; Johansson A; Phelps R; Shady AA; Ramirez MC; Yasuda M; Caro A; Desnick RJ Am J Hum Genet; 2006 Apr; 78(4):645-58. PubMed ID: 16532394 [TBL] [Abstract][Full Text] [Related]
34. Gene transfer of the uroporphyrinogen III synthase cDNA into haematopoietic progenitor cells in view of a future gene therapy in congenital erythropoietic porphyria. Mazurier F; Moreau-Gaudry F; Salesse S; Barbot C; Ged C; Reiffers J; de Verneuil H J Inherit Metab Dis; 1997 Jun; 20(2):247-57. PubMed ID: 9211197 [TBL] [Abstract][Full Text] [Related]
35. Correction of deficient CD34+ cells from peripheral blood after mobilization in a patient with congenital erythropoietic porphyria. Mazurier F; Géronimi F; Lamrissi-Garcia I; Morel C; Richard E; Ged C; Fontanellas A; Moreau-Gaudry F; Morey M; de Verneuil H Mol Ther; 2001 Mar; 3(3):411-7. PubMed ID: 11273784 [TBL] [Abstract][Full Text] [Related]
36. Porphyrins in urine, plasma, erythrocytes, bile and faeces in a case of congenital erythropoietic porphyria (Gunther's disease) treated with blood transfusion and iron chelation: lack of benefit from oral charcoal. Gorchein A; Guo R; Lim CK; Raimundo A; Pullon HW; Bellingham AJ Biomed Chromatogr; 1998; 12(6):350-6. PubMed ID: 9861496 [TBL] [Abstract][Full Text] [Related]
37. Congenital erythropoietic porphyria: report of a novel mutation with absence of clinical manifestations in a homozygous mutant sibling. Ged C; Mégarbané H; Chouery E; Lalanne M; Mégarbané A; de Verneuil H J Invest Dermatol; 2004 Sep; 123(3):589-91. PubMed ID: 15304101 [TBL] [Abstract][Full Text] [Related]